Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Cancer, Muscle-invasive

Explore clinical trials studying Urinary Bladder Cancer, Muscle-invasive. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Cancer, Muscle-invasive trial results

Active, Not Recruiting

Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Participants Who Are Cisplatin-ineligible or Decline Cisplatin With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303)

NCT03924895

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • University of South Alabama, Mitchell Cancer Institute ( Site 1582) Mobile, Alabama, United States
  • CARTI Cancer Center ( Site 1577) Little Rock, Arkansas, United States
  • St. Joseph Heritage Healthcare ( Site 0046) Fullerton, California, United States
  • Scripps MD Anderson ( Site 0010) La Jolla, California, United States
View all 242 locations
View Trial Details

Related conditions